top of page
最新
動態
APASL Okuda Omata Distinguished Award 2023: Prof. George Lau
Seeking a “CURE” for liver diseases-a thirty years’ journey of a hepatologist
Outcomes by occurrence of immune-mediated adverse events with tremelimumab plus duralumab in the Phase 3 HIMALAYA study in unresctable hepatocellar carsinoma
Outcomes by occurrence of immune-mediated adverse events with tremelimumab plus duralumab in the Phase 3 HIMALAYA study in unresctable hepatocellar carsinoma
天下仁心醫療集團主席廖家傑醫生接受大公報專訪
廖家傑醫生近日接受大公報記者專訪時，談及自己一路以來與肝病研究共同走過的經歷，希望可以積極推動肝病研究成果的臨床轉化，幫助更多國人擺攤肝病困擾
bottom of page